Thu. 9 May 2024, 5:05pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $7.966 million which missed the analyst consensus estimate of $8.000 million by 0.43 percent. This is a 50.19 percent increase over sales of $5.304 million the same period last year.